Review of cardiovascular involvements in COVID-19

Background: A spectrum of cardiovascular pathologies occurs in patients with COVID-19 and increases the risk of mortality. Risk of mortality is also heightened in cardiovascular disease patients who contact COVID-19. Methodology: Online search for the keywords in PubMed, Medline, Embase, Google sch...

Full description

Bibliographic Details
Main Authors: Ekpe EE, Umoh IA, Shogade TT, Eyo CS, Akpan AF
Format: Article
Language:English
Published: Nigerian Medical Association, Akwa Ibom State Branch 2021-10-01
Series:Ibom Medical Journal
Subjects:
Online Access:https://ibommedicaljournal.org/index.php/imjhome/article/view/40
_version_ 1797271914361651200
author Ekpe EE
Umoh IA
Shogade TT
Eyo CS
Akpan AF
author_facet Ekpe EE
Umoh IA
Shogade TT
Eyo CS
Akpan AF
author_sort Ekpe EE
collection DOAJ
description Background: A spectrum of cardiovascular pathologies occurs in patients with COVID-19 and increases the risk of mortality. Risk of mortality is also heightened in cardiovascular disease patients who contact COVID-19. Methodology: Online search for the keywords in PubMed, Medline, Embase, Google scholar was done. Relevant research articles yielded from the searches were reviewed. Results: the searches yielded a total of 172 results, out of which 111 were reviewed. Cardiac involvement was found in 70.6% COVID-19 patients: tachycardia (19%), electrocardiography abnormalities (22%), echocardiography abnormalities (57%), elevated myocardial enzymes (53%), and acute cardiac injury (9%). Eight percent of patients with acute cardiac injury were aged >60 years; 87.5% of them had ≥2 underlying comorbidities (hypertension, diabetes mellitus, cardiovascular diseases, chronic obstructive pulmonary disease, and chronic kidney disease). Novel coronavirus pneumonia was much more severe in the patients with acute cardiac injury than in patients with non-definite acute cardiac injury (P<0.001). Multivariate analyses showed that C-reactive protein (CRP) levels, old age, novel coronavirus pneumonia severity, and underlying comorbidities were the risk factors for cardiac abnormalities in patients with COVID-19. Conclusion: Besides its prominent expression at the level of the respiratory apparatus, COVID-19 is also characterized by a substantial degree of cardiovascular involvement, both in terms of deterioration of pre-existing conditions, and as the effect of inflammation-facilitated acute events. They include ischemic and inflammatory heart disease, ventricular arrhythmias, conduction disturbances, thrombotic events at the level of the lungs, systemic activation of the coagulation cascade and disseminated intravascular coagulation.
first_indexed 2024-03-07T14:17:01Z
format Article
id doaj.art-ee2d0bfa5b9c40648594ee213f3a1a94
institution Directory Open Access Journal
issn 1597-7188
2735-9964
language English
last_indexed 2024-03-07T14:17:01Z
publishDate 2021-10-01
publisher Nigerian Medical Association, Akwa Ibom State Branch
record_format Article
series Ibom Medical Journal
spelling doaj.art-ee2d0bfa5b9c40648594ee213f3a1a942024-03-06T12:03:12ZengNigerian Medical Association, Akwa Ibom State BranchIbom Medical Journal1597-71882735-99642021-10-0114410.61386/imj.v14i4.40Review of cardiovascular involvements in COVID-19Ekpe EE0Umoh IAShogade TTEyo CSAkpan AFCardiothoracic Surgery Unit, Department of Surgery, Faculty of Clinical Sciences, College of Health Sciences, University of Uyo, Nigeria Background: A spectrum of cardiovascular pathologies occurs in patients with COVID-19 and increases the risk of mortality. Risk of mortality is also heightened in cardiovascular disease patients who contact COVID-19. Methodology: Online search for the keywords in PubMed, Medline, Embase, Google scholar was done. Relevant research articles yielded from the searches were reviewed. Results: the searches yielded a total of 172 results, out of which 111 were reviewed. Cardiac involvement was found in 70.6% COVID-19 patients: tachycardia (19%), electrocardiography abnormalities (22%), echocardiography abnormalities (57%), elevated myocardial enzymes (53%), and acute cardiac injury (9%). Eight percent of patients with acute cardiac injury were aged >60 years; 87.5% of them had ≥2 underlying comorbidities (hypertension, diabetes mellitus, cardiovascular diseases, chronic obstructive pulmonary disease, and chronic kidney disease). Novel coronavirus pneumonia was much more severe in the patients with acute cardiac injury than in patients with non-definite acute cardiac injury (P<0.001). Multivariate analyses showed that C-reactive protein (CRP) levels, old age, novel coronavirus pneumonia severity, and underlying comorbidities were the risk factors for cardiac abnormalities in patients with COVID-19. Conclusion: Besides its prominent expression at the level of the respiratory apparatus, COVID-19 is also characterized by a substantial degree of cardiovascular involvement, both in terms of deterioration of pre-existing conditions, and as the effect of inflammation-facilitated acute events. They include ischemic and inflammatory heart disease, ventricular arrhythmias, conduction disturbances, thrombotic events at the level of the lungs, systemic activation of the coagulation cascade and disseminated intravascular coagulation. https://ibommedicaljournal.org/index.php/imjhome/article/view/40COVID-19Cardiovascular manifestationcardiac involvementcardiac affectation
spellingShingle Ekpe EE
Umoh IA
Shogade TT
Eyo CS
Akpan AF
Review of cardiovascular involvements in COVID-19
Ibom Medical Journal
COVID-19
Cardiovascular manifestation
cardiac involvement
cardiac affectation
title Review of cardiovascular involvements in COVID-19
title_full Review of cardiovascular involvements in COVID-19
title_fullStr Review of cardiovascular involvements in COVID-19
title_full_unstemmed Review of cardiovascular involvements in COVID-19
title_short Review of cardiovascular involvements in COVID-19
title_sort review of cardiovascular involvements in covid 19
topic COVID-19
Cardiovascular manifestation
cardiac involvement
cardiac affectation
url https://ibommedicaljournal.org/index.php/imjhome/article/view/40
work_keys_str_mv AT ekpeee reviewofcardiovascularinvolvementsincovid19
AT umohia reviewofcardiovascularinvolvementsincovid19
AT shogadett reviewofcardiovascularinvolvementsincovid19
AT eyocs reviewofcardiovascularinvolvementsincovid19
AT akpanaf reviewofcardiovascularinvolvementsincovid19